Skip to main content
. 2018 Apr 25;19(8):735–744. doi: 10.1080/15384047.2018.1453971

Figure 2.

Figure 2.

H&E-stained colorectal sections from model mice and drug-treated mice (50× ). (A) Naringin prevented colorectal inflammation. A-a. normal mice; A-b. model mice; A-c. Naringin with 50 mg/kg treated mice; A-d. Naringin with 100 mg/kg treated mice; A-e. Aspirin-treated mice. (B) Naringin reduced colitis evaluated by inflammation score. *P < 0.05, **P < 0.01 between model mice and drug-treated mice. #P < 0.05, ##P < 0.01 between naringin and aspirin. (C) Naringin prevented inflammation-driven colorectal adenomas. C-a. model mice; C-b. Naringin 50 mg/kg; C-c. Naringin 100 mg/kg; B-d. Aspirin 100 mg/kg.